Technological Advances in EUS-Guided Assessment of Pancreatic Cysts

Video Transcription

Video Summary

Welcome to ASGE Gastrointestinal Endoscopy 2021, New Frontier in ERCP and EUS. Today's satellite symposium is entitled Technological Advances in EUS-Guided Assessment of Pancreatic Cysts, and it is brought to you by Steris Endoscopy. Dr. Christopher DeMeo, the Director of Interventional Endoscopy at Mount Sinai Hospital, will present on the topic. Pancreatic cysts are common and have the potential for malignant transformation, so it is important to accurately diagnose and manage them. Current diagnostic tools, such as imaging and cyst fluid analysis, have limitations in providing a definitive diagnosis. However, technological advances in EUS, such as confocal laser endomicroscopy (NCLE) and needle-based confocal laser endomicroscopy, have shown promise in improving diagnostic yield. NCLE allows for real-time imaging of the cyst wall, providing specific features that can differentiate different types of cystic lesions. Microforceps biopsy, on the other hand, allows for direct tissue sampling for histologic analysis. These advanced tools have shown improved diagnostic accuracy compared to standard cyst fluid analysis and cytology. In a study that included both NCLE and microforceps biopsy, there was a significant change in clinical management based on the results, with many patients being able to avoid unnecessary surgery or long-term surveillance. However, it is important to consider the risks associated with these procedures, such as bleeding and pancreatitis, and to carefully select patients who will benefit from these advanced diagnostic tools. That concludes the summary of the video content.

Keywords

EUS-Guided Assessment

Pancreatic Cysts

Technological Advances

Confocal Laser Endomicroscopy

Microforceps Biopsy

Diagnostic Accuracy

Clinical Management

Advanced Diagnostic Tools

Pancreatitis